Three Psychedelic Companies Analysts Say Could Be Acquired Next
The Deal That Changed the Temperature Eli Lilly agreed in July to pay up to $3.8 billion for AtaiBeckley. That
Read More
The Deal That Changed the Temperature Eli Lilly agreed in July to pay up to $3.8 billion for AtaiBeckley. That
Read More
FDA heard four hours of testimony on psychedelic approval and asked no questions. The real contest was over label language,
Read More
Vanderbilt has funding to test IV ketamine for depression in people with mild cognitive impairment or early Alzheimer’s, the medical
Read More
Did Senate Bill 519 come too soon in the state of California?
Read More
Is it possible to not only stop your mushrooms from degrading, but actually increasing in potency? Science says yes.
Read More
Despite its widespread use and growing popularity, some people worry: if I use MDMA, will it show up on a
Read More
What happens when a blind person takes psychedelics? Zeus Tipado explains the unique process in the brain.
Read More
Should MDMA therapy be considered even if you're regularly taking antidepressants?
Read More
Like most things in life, ayahuasca retreats don't always deliver the same experience.
Read More
Get to know wavy cap mushrooms (Psilocybe cyanescens), understanding their potency and effects.
Read More